Navigation Links
Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc
Date:5/1/2012

LOS ANGELES, May 1, 2012 /PRNewswire/ -- Intrepid Investment Bankers LLC ("Intrepid"), a leading middle market investment banking firm, today announced the sale of Newport Medical Instruments, Inc. ("Newport") to Covidien plc (NYSE: COV).  The transaction closed on May 1, 2012.  Intrepid acted as the exclusive M&A advisor to Newport in connection with the transaction. 

(Logo:  http://photos.prnewswire.com/prnh/20120315/LA70428LOGO)

Newport is a physician-led company, focused solely on the design and manufacture of dependable, life improving ventilators that are affordable for caregivers worldwide. Newport's products are sold in the United States and more than 115 countries worldwide.

Covidien is a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices.  Covidien creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries.

"This transaction highlights both companies' commitment to driving innovation and growth in the respiratory care sector by expanding their ventilator portfolio and global presence," said Dr. Hong-Lin Du, President of Newport.  "Newport shareholders were very pleased with the strategic guidance and process advice Intrepid has provided."

Mr. Ed Bagdasarian, Managing Director of Intrepid, commented, "We were pleased to have the opportunity to work with the Newport owners and management team to lead the company through the sale process.  After three decades of building the company, its owners decided to entertain strategic discussions with partners that would help accelerate the fulfillment of several exciting growth opportunities.  We were honored to play a part in selecting its future partner and completing a transaction that will help Newport realize its growth opportunities."

The Intrepid team included Ed Bagdasarian, Steve Davis, Adam Abramowitz, Jeremy Lai and Meghan Stenger.

About Intrepid Investment Bankers LLC 

Intrepid Investment Bankers LLC, based in Los Angeles, California, is a mergers and acquisitions and corporate finance advisory firm focused on the middle-market. Intrepid was founded in 2010 by the former principals of Barrington Associates, a firm that grew to become a leading national middle market M&A advisor before its acquisition by Wells Fargo in 2006. Intrepid's services include M&A advisory, equity and debt capital raising and providing strategic advice in complex securities transactions. The firm focuses on the middle market corporate finance needs of entrepreneur and family-owned businesses, private equity sponsors and major corporations. Collectively, the senior team at Intrepid brings over 100 years of mergers and acquisitions advisory experience and has advised on over 250 transactions spanning a broad range of industries, including consumer products and services, industrial manufacturing, healthcare products and services, building products, business services and retail. www.intrepidib.com Member FINRA/SIPC. 


'/>"/>
SOURCE Intrepid Investment Bankers LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
2. IRIDEX to Present at Upcoming Investment Conferences
3. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
4. Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
5. Quanterix Announces Strategic Investment From IQT
6. Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
7. Healthcare Services No Longer "Restricted" in Chinas Foreign Investment Catalogue
8. AuraSense Therapeutics Secures Series B Equity Investment
9. Cardium and SourceOne Global Partners Enter Into Cross-Strategic Equity Investment with Plans to Jointly Develop Nutritional Supplements and Medical Foods
10. Physicians Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX
11. Physicians Capital Investments Announces Pedro Vergne-Marini, MD Named to Beckers ASC Review "350 People in the ASC Industry to Know"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
Breaking Medicine Technology:
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The Patient ... Baltimore Health System, with the 2017 Ruth Ravich Patient Advocacy Award in ... patient advocates. DeVaro was honored with the award at The Beryl Institute’s annual ...
(Date:4/21/2017)... ... April 21, 2017 , ... The ... A Week of Addiction and Recovery Education, from April 24 to April 28, ... substance use disorders. , The mission of AWARE is to instill a ...
(Date:4/21/2017)... UK (PRWEB) , ... April 21, 2017 , ... ... for Enterprise in the category of International Trade, the UK’s most prestigious award ... international trade, which represents 95% of total revenues and has grown by a ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Westside ... experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become one ... to help my numerous clients over the years with all their dental needs,” said ...
(Date:4/21/2017)... ... April 21, 2017 , ... Federal ... five common elements between the Obamacare program that most Republicans love to hate ... Warfarin poison to kill hogs. , Like Obamacare, the Miller program centers ...
Breaking Medicine News(10 mins):